Nakayama Tetsuzo, Hirano Katsuya, Shintani Yoshinobu, Nishimura Junji, Nakatsuka Akio, Kuga Hirotaka, Takahashi Shosuke, Kanaide Hideo
Division of Molecular Cardiology, Research Institute of Angiocardiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Br J Pharmacol. 2003 Jan;138(1):121-30. doi: 10.1038/sj.bjp.0705008.
1 Using fura-2 fluorometry of Ca(2+) in response to thrombin, trypsin and protease-activated receptor activating peptides (PAR-APs), we determined whether trypsin cleaves protease-activated receptor 1 (PAR1) and activates it in the endothelial cells of the porcine aortic valves and human umbilical vein. 2 Once stimulated with thrombin, the subsequent application of trypsin induced a Ca(2+) elevation similar to that obtained without the preceding stimulation with thrombin in the valvular endothelial cells. However, the preceding stimulation with trypsin abolished the subsequent response to thrombin, but not to bradykinin or substance P. 3 The response to PAR1-AP (SFLLRNP) was significantly (P<0.05) reduced by the preceding stimulation with thrombin and PAR1-AP in the valvular endothelial cells, while, importantly, it remained unaffected by the preceding stimulation with either trypsin or PAR2-AP (SLIGRL). The response to PAR2-AP was reduced by the preceding stimulation with trypsin and PAP2-AP. PAR1-AP attenuated the subsequent responses not only to thrombin and PAR1-AP but also to trypsin and PAR2-AP, while PAR2-AP specifically attenuated the subsequent responses to trypsin and PAR2-AP. 4 In human umbilical vein endothelial cells, a higher affinity PAR1-AP (haPAR1-AP) (Ala-pF-Arg-Cha-HArg-Tyr-NH(2)) specifically attenuated the responses to thrombin but not trypsin. On the other hand, the response to haPAR1-AP was significantly (P<0.05) attenuated by the preceding stimulation with thrombin but not trypsin. 5 In conclusion, trypsin cleaved PAR1 but did not activate it in the endothelial cells. Moreover, the trypsin-cleaved PAR1 was no longer responsive to thrombin.
利用fura - 2荧光法检测猪主动脉瓣和人脐静脉内皮细胞中Ca(2 +)对凝血酶、胰蛋白酶和蛋白酶激活受体激活肽(PAR - APs)的反应,我们确定胰蛋白酶是否能切割蛋白酶激活受体1(PAR1)并在这些细胞中激活它。
一旦用凝血酶刺激后,随后施加胰蛋白酶会诱导Ca(2 +)升高,这与在瓣膜内皮细胞中未先用凝血酶刺激时获得的升高相似。然而,先用胰蛋白酶刺激会消除随后对凝血酶的反应,但不会消除对缓激肽或P物质的反应。
在瓣膜内皮细胞中,先用凝血酶和PAR1 - AP刺激会显著(P<0.05)降低对PAR1 - AP(SFLLRNP)的反应,而重要的是,先用胰蛋白酶或PAR2 - AP(SLIGRL)刺激对其没有影响。先用胰蛋白酶和PAP2 - AP刺激会降低对PAR2 - AP的反应。PAR1 - AP不仅减弱随后对凝血酶和PAR1 - AP的反应,还减弱对胰蛋白酶和PAR2 - AP的反应,而PAR2 - AP特异性减弱随后对胰蛋白酶和PAR2 - AP的反应。
在人脐静脉内皮细胞中,一种高亲和力的PAR1 - AP(haPAR1 - AP)(Ala - pF - Arg - Cha - HArg - Tyr - NH(2))特异性减弱对凝血酶的反应,但不减弱对胰蛋白酶的反应。另一方面,先用凝血酶刺激会显著(P<0.05)减弱对haPAR1 - AP的反应,但先用胰蛋白酶刺激则不会。
总之,胰蛋白酶能切割PAR1,但在这些内皮细胞中不会激活它。此外,经胰蛋白酶切割后的PAR1对凝血酶不再有反应。